In order to understand the mechanisms of interaction between tonin-angiotensin and renin-angiotensin systems (RAS) we evaluated, "in vivo" and "in vitro", in Wistar rats, cardiovascular and electrocardiographic parameters after tonin administration. Arterial pressure (AP) and electrocardiogram (ECG) were recorded in awake animals before and after tonin administration. Langendorff technique was used to analyze cardiac function in isolated heart in the presence of tonin and video motion edge detection system was used to evaluate the effect of tonin upon contractile function of isolated rat ventricular cardiomyocytes. After tonin infusion rats presented significantly higher diastolic and mean arterial pressure (MAP) and heart rate (HR) as compared with control. The ECG analysis revealed shorter RR interval, increase in the low-frequency (LF) range of the heart rate variability (HRV) power (%) and decrease in the high-frequency (HF) of HRV power (%). Isolated hearts perfused with tonin presented an increase in the arterial coronary pressure (ACP) and decline in the ventricular systolic tension (ST), maximal (dT/dt+) and minimal (dT/dt) contractility. The rates of contraction and relaxation of isolated ventricular cardiomyocytes were significantly increased due to the presence of tonin. The angiotensin II (Ang II) levels in the coronary sinus effluent increased in the presence of tonin in a dose-dependent manner and the effect of tonin upon ACP was completely blocked by candesartan. Tonin is able to generate the vasoconstrictor peptide Ang II in the isolated heart of the rat and the cardiovascular response induced by tonin was completely blocked by candesartan, an indication that the action of Ang II on Ang II type 1 (AT1) receptors is the major mechanism of the heart effects. Tonin affects cardiomyocyte contractile function which may be due to interference with Ca 2+ handling.
Introduction
The renin-angiotensin system (RAS) is well known for its regulation of blood pressure (BP) and fluid homeostasis. The RAS participates in changes in chronotropism, inotropism, arrhythmogenesis and cellular growth in the heart [1] . Ang II, the effector of the system causes vasoconstriction directly and indirectly by stimulating angiotensin II (Ang II) type 1 (AT1) receptors present on the vasculature and by increasing sympathetic tone [2] . All components of the RAS can be found in the heart, vasculature, kidney, among others [3] . Even though some authors speculate on the putative mechanism of renin uptake from the plasma into the heart, it is well described that renin synthesis in the heart is approximately 2% of that of the kidney [4] .
The existence of alternative Ang II generating systems in different sites of cardiovascular importance suggests diverse physiological effects for these systems in the local control of blood flow and in the pathophysiology of hypertension and cardiovascular diseases [5] . These systems, involving proteinases other than renin and the angiotensin converting enzyme (ACE), have been shown in several species including human [6] [7] [8] .
An enzyme that represents a good candidate to be involved in the Ang II generation as an alternative route is the serine proteinase tonin, which is able to release Ang II directly from angiotensinogen (AG) [9] . Tonin is present in many organs of the rat, such as the heart, brain, prostate and submandibular gland [10] [11] [12] . Tonin may also release Ang II from peptides presenting the sequence corresponding to the N-terminal portion of AG including angiotensin I (Ang I) and the tetradecapeptide (AG (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) ) [7] , the synthetic renin substrate. The Regulatory Peptides 181 (2013) [30] [31] [32] [33] [34] [35] [36] observed specificity of the enzyme supports a possible important role of tonin for local Ang II liberation in tissues [13] .
In 2003, Borges [12] and collaborators presented evidences that tonin may participate in the process of cardiac hypertrophy in the rat. These authors showed that Wistar rats with isoproterenolinduced cardiac hypertrophy presented increased levels of tonin activity and expression of tonin and AG in the atria. No change was observed in the levels of expression and activity of ACE or renin in cardiac tissue of these animals when compared with the control group. Therefore, to advance in the characterization of the physiological role of tonin more recently our group generates transgenic mice that express rat tonin (TGM(rTon)). These mice present high levels of tonin mRNA and activity specifically in the brain. As a consequence, TGM(rTon) develop increased BP and water intake [14] .
In order to understand the mechanisms of interaction between toninangiotensin and RAS in the heart, we evaluated "in vivo" and "in vitro" cardiovascular and electrocardiographic parameters of male Wistar rats after tonin administration. Isolated working hearts were used to separate the effects of the local and systemic RAS. In addition, the effect of tonin upon contractile function of isolated rat cardiomyocytes was analyzed.
Experimental procedures

Animals
Experiments were performed in male Wistar rats (250-300 g) from the main breeding stock of the Institute of Biological Sciences (Federal University of Minas Gerais, Brazil). Animals were housed individually in plastic cages, under controlled light conditions (lights on at 6:00 am and off at 8:00 pm), room temperature at 24°C with food and water ad libitum. Efforts were made to avoid any unnecessary distress to the animals and all animal procedures were performed in accordance with institutional guidelines approved by the Ethics Committee in Animal Experimentation of the Federal University of Minas Gerais, Brazil (CETEA-UFMG), which are in accordance with the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals. The animals were randomly divided into 3 groups: a) in vivo group-BP, ECG and HR measurements, b) in vitro group-for systolic and diastolic tension analysis in isolated hearts and c) cardiomyocytes group, for contractile function determination in isolated ventricular myocytes.
Blood pressure
Twenty-four hours before the experiment the animals were anesthetized with 2.5% tribromoethanol (1 mL/100 g of body weight, i.p., Sigma-Aldrich, Inc.) and polyethylene catheters (PE-10 connected to PE-50) were inserted into abdominal aorta through the left femoral artery and into the femoral vein for recording of BP and drug infusion, respectively. The catheters were tunneled subcutaneously and exteriorized backing the cervical region of the animal. Five Wistar rats were used for BP measurements. Highly purified tonin [10] was injected into the femoral catheter. MAP and systolic and diastolic arterial pressure (SAP and DAP, respectively) were monitored simultaneously during experiments by a solid-state strain gauge transducer (TSD 104A, Biopac Systems, Inc., CA, USA). The transducer was connected to a computer through a data acquisition system (MP100; Biopac Systems, Inc., CA, USA). The data were analyzed by the AcqKnowledge Software. The experiments were conducted in conscious and freely moving rats.
Electrocardiogram and heart rate variability
To obtain ECG tracings five Wistar rats were anesthetized with 2.5% tribromoethanol (1 mL/100 g of body weight, i.p., Sigma-Aldrich, Inc.) and a bipolar platinum electrode was positioned in the thorax (subcutaneous tissue) directly in derivation DII [15] . The ECG recordings were performed 24 h after the implantation of the electrode and catheters. Highly purified tonin [10] was injected into the femoral catheter. ECG was evaluated in conscious, freely moving rats. The RR and PR intervals, QT interval duration, corrected QT (QTc) and the QRS complex were analyzed. The QT interval was measured starting from the onset of the QRS complex until the end of the T wave, which is the return of the T wave to the baseline. QTc was obtained using Bazett's formula (QTc= QT/ √RR) [16] . The HRV was calculated by Kubios software from successive RR interval obtained from the ECG tracings. In the time-domain analysis, the following indexes were evaluated: standard deviation of RR intervals (SDNN) and square root of the mean squared differences of successive RR intervals (RMSSD). Additionally, in the frequency-domain analysis of HRV the LF power (%) and the HF power (%) were evaluated [17] .
Isolated hearts
Thirty five Wistar rats were used for cardiac function evaluation. The hearts were isolated and perfused (8.0± 0.2 mL/min) as previously described [18] . All experiments were initiated after a 10-min stabilization period. The drugs were dissolved in KRS (perfusion fluid containing: 118.4 mM NaCl, 4.7 mM KCl, 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 -7H 2 O, 2.5 mM CaCl 2 -H 2 O, 11.7 mM glucose and 26.5 mM NaHCO 3 ) to obtain the desired final concentration. Highly purified tonin [10] was added to the perfusing KRS to 8, 16, 32 and 64 ng/mL and administered to each group separately. The dose of 32 ng/mL was administered in the presence or not of 1 nM candesartan. In the doses of 16 and 64 ng/mL, the coronary sinus effluent was collected (at 0, 5, 10, 15, 20, 25 and 30 min) and subsequently assayed for Ang II by specific radioimmunoassay [19] . Mechanical parameters such as systolic and diastolic tensions and arterial coronary pressure (ACP) were measured throughout the experiment. A force transducer (model FT3, Grass) was attached through a heart clip to the apex of the ventricles to record the contractile force (tension, g) in a computer using a data acquisition system (Biopac System, Inc., CA, USA). A diastolic tension of 1.0 ±0.1 g was applied to the hearts [20] and we also evaluated the tension developed by the hearts by calculating the derivatives (±dT/dt) using the software AcqKnowledge Version 3.5.7 (Biopac System, Inc., CA, USA). Maximum dT/dt is a reasonable index of the initial velocity of myocardial contraction and minimum dT/dt with myocardial relaxation.
Isolated cardiomyocyte
Left ventricular myocytes were isolated as previously described [21] . Cell contractile function was evaluated as previously described [21] . Briefly, isolated cells were placed in a chamber with a glass coverslip base mounted on the stage of an inverted microscope (Nikon Eclipse TS100). Cells were perfused with HEPES Tyrode's solution containing 1 mM CaCl 2 plus 0, 10, 15 or 20 ng/mL of tonin, and field stimulated at the frequency of 1 Hz (20 V, 5 ms duration square pulses) via platinum bath electrodes (MyoPacer field stimulator; IonOptix, Milton, MA). Cells were visualized on a personal computer monitor with a NTSC camera (MyoCam; IonOptix) in partial scanning mode. This image was used to measure cell shortening (our index of contractility) in response to electrical stimulation using a video motion edge detector (IonWizard; IonOptix). All parameters were evaluated using customized software developed in the MatLab® platform. Cell shortening from stimulation (expressed as a percentage of resting cell length), time to peak of shortening and time to half relaxation were measured and calculated as previously described [22] . We evaluated 32-38 cells per animal in each experimental group. Only calcium-tolerant, quiescent, rod-shaped cardiomyocytes showing clear cross striations were studied.
Statistical analysis
Statistical analysis was performed using Graph-Pad Prism 4 (GraphPad Software, Inc.). Data are reported as mean± SEM. Significant statistical differences were determined with One-way ANOVA followed by the Newman-Keuls post-test or the Dunnett's post-test, ANOVA one way on Ranks plus Dunn's, Two-way ANOVA followed by the Bonferroni post-test or Student's t-test. Values of p b 0.05 were considered to be statistically significant.
Results
As compared with control (basal conditions), Wistar rats presented significantly higher DAP and MAP after tonin injection (Fig. 1) . The basal values for DAP, SAP and MAP were 102 ± 4 mm Hg, 135± 4 mm Hg and 120 ±3 mm Hg, respectively. After injection of the enzyme, a significant elevation of DAP (122±2 mm Hg; p b 0.01) and MAP (132± 1 mm Hg; p b 0.05) was observed. Increase in the HR was also observed (Fig. 2) . The values of HR were 371 ± 12 bpm in basal condition (control) and 506± 17 bpm [maximum heart rate (HRmax)] after tonin infusion. Increase in HR and BP was observed 1 min after tonin infusion. However, the increase in HR remained elevated, lasts for longer than 10 min.
Increased BP and HR are associated with decreased HRV. Therefore, to better understand the physiological role of tonin in the dynamic autonomic regulation of HR, we examined the effects of intravenous administration of tonin upon HRV in Wistar rats. Time-and frequencydomain HRV analyses were conducted under basal condition and after tonin infusion (5000 ng/kg, iv). Time domain analysis of HRV before tonin infusion showed higher values when compared with values after infusion (SDNN: 4.76 ±0.65 vs 1.06± 0.16 ms, n = 5, p b 0.01; RMSSD: 5.00 ±0.67 vs 1.90± 0.51 ms, n = 5, p b 0.01, Student's t-test). Additionally, the frequency-domain analysis of HRV evidenced an imbalance of the autonomic control with a significant difference between LF power (%) (Fig. 3A) , and no significant differences in HF power (%) were observed (Fig. 3B) . However, differences in LF power (%) and HF power (%) contribute to a significant increased in LF/HF ratios (Fig. 3C) . These data evidenced an increase in the sympathetic tone after tonin infusion. Taken together, these findings suggest that tonin may cause an imbalance of the autonomic control of the heart with increases in the sympathetic tone.
The ECG analysis revealed that after tonin infusion Wistar rats presented shorter RR interval (Fig. 4A) , reflecting the higher HR seen in these animals. A shortening of the QT interval was also observed after tonin infusion (Fig. 4C) , even though QT parameters corrected for HR (QTc) were not different (Fig. 4D) . The QRS complex (Fig. 4E ) and PR interval (Fig. 4B ) did not differ from the control, indicating that the atrioventricular nodal conduction and ventricular conduction were normal after tonin injection. Isolated rat hearts perfused with KRS plus tonin presented an increase in the ACP (Fig. 5A) and reduction in the ventricular systolic tension (ST) (Fig. 5B ) when compared to the control (isolated rat hearts perfused with KRS without tonin). Maximal (dT/dt+) and minimal contractility (dT/dt −) were also recorded ( Fig. 5C and D, respectively) . The effect of tonin injection upon ACP and ventricular ST may be due to tonin-Ang II releasing since the effect upon ACP was completely blocked by previously administered candesartan (Fig. 6 ) and the levels of Ang II in the coronary sinus effluent increased in a dose-dependent manner after tonin injection (Fig. 7) . Levels of Ang II ranged from 19.0±2.3×10
−10 mol/L before tonin injection to 33.0±4.0×10 −10 mol/L and 60.0±5.0×10 −10 mol/L after tonin injection at 16 ng/mL and 64 ng/mL, respectively. To determine if the decrease in ST of isolated heart induced by tonin is occurring at the cellular level we examined cell contractile function in ventricular myocytes freshly isolated from Wistar rats. The results showed alteration in the rates of contraction and relaxation of myocytes due to the presence of tonin. The time to peak of cell shortening was significantly reduced (Fig. 8B) and the time to half relaxation was significantly faster (Fig. 8C) . However, no changes were observed upon inotropic effect (cell shortening, Fig. 8A ).
Discussion
In the present study it was observed that femoral injection of tonin into Wistar rat induces significant increase in the DAP, MAP and HR. Pressor and HR effects of tonin were already described by Araujo et al. [11] . These authors observed significant elevation of MAP (20-30% of basal value) with simultaneous increase in HR when tonin was injected into the third ventricle of the brain.
The tachycardia observed by us in this study may be due to an increase in the intrinsic heart rate caused by increased sympathetic tone and augment in the activity levels of the components of the RAS. Machado and Brody [23] reported that the tachycardia can be directly related to the intrinsic heart rate increase arising from increased sympathetic tone. Changes in cardiac autonomic balance with predominance of parasympathetic over sympathetic tone were evidenced as the determinant of the basal HR.
Tonin activity is characterized by the release of the vasoconstrictor peptide Ang II [9] that in turn causes acutely, increase in BP by acting directly to constrict vascular smooth muscle. Greater increase in the diurnal BP (ΔMAP= 37± 1.8 mm Hg), determined by telemetry in Wistar rat was observed with continuous Ang II infusion (6 μg/h) [24] . Xu and Sved [25] observed that the Ang II-induced increase in MAP was accompanied by bradycardia while the results of the present study demonstrate tachycardia, probably due to stimulation of sympathetic outflow. In this study we are demonstrating for the first time that intravenous injection of tonin increased the LF component of the HRV. These results suggested the possibility that tonin infusion increased sympathetic tone and caused an imbalance of autonomic control of the heart. Abnormal cardiac autonomic control including high levels of sympathetic activity and impaired parasympathetic control is associated with cardiac dysfunction [26] .
In anesthetized rabbits, Kawada et al. [27] demonstrated that the disproportional suppression of the dynamic vagal and sympathetic regulation of HR would result in a relative sympathetic predominance in the presence of Ang II. Akselrod et al. [28] observed that the RAS modulates the amplitude of the spectral peak located at 0.04 Hz and the authors suggest that the LF peak is related to cyclic fluctuations in peripheral vasomotor tone. In accordance with Kawada et al. [27] , the reduced HF component of HRV in patients with cardiovascular diseases may be explained at least in part by the peripheral effects of Ang II on the dynamic autonomic regulation of HR. Evidence has also been provided that Ang II plays a facilitatory role on the neuroadrenergic transmission across sympathetic ganglia; potentiates norepinephrine release from sympathetic nerve terminals via stimulation of presynaptic angiotensinergic receptors, and expands the alpha-receptor mediated vasoconstrictor responses to exogenously administered or endogenously produced norepinephrine [29, 30] .
Patil et al. [31] observed that distinct colocalization of neuronal Ang II with dopamine-β-hydroxylase in the heart may indicate that Ang II participates together with norepinephrine in the regulation of cardiac functions: Produced as a cardiac neurotransmitter Ang II may have inotropic, chronotropic or dromotropic effects in atria and ventricles and contributes to blood pressure regulation [31] . Direct vasoconstrictor effects of Ang II on the coronary vasculature through binding to the AT1 receptor, may importantly influence myocardial perfusion [32] and induce negative inotropic effects [33] . In the present study, tonin induced coronary vasoconstriction and at the same time depressed myocardial contractility. This large heterogeneity in the type of inotropic response to Ang II in cardiac muscle suggests the possibility that the final effect of Ang II on cardiac excitation-contraction coupling and inotropism may result from a complex balance between several opposing mechanisms. The negative contractile effect of the peptide was observed in the rat heart [33] , papillary muscles of infarcted and noninfarcted rats [34] and in cardiac myocytes [35] . Infusion of Ang II at 1 μM produces a negative inotropic effect that is not associated with an observed parallel decrease in the intracellular Ca 2+ transient, indicating that the decrease in myofilament responsiveness to Ca 2+ levels underlies the reduction in contractility [35] . Decrease in ST may be correlated with coronary pressure. Downey [36] observed in his studies that decrease in total coronary blood flow reduces contractile force. In accordance with Schulz and Heusch [37] , left ventricular mechanical function is very sensitive to reductions in left coronary blood flow and Morita et al. [38] demonstrated that α-adrenergic-mediated left coronary vasoconstriction reduced systolic retrograde coronary flow.
The effects of tonin upon ACP were completely blocked by previously administered candesartan. Candesartan selectively blocks the AT1 receptor [39] , therefore, unaltered levels of coronary pressure before exposure to tonin in the presence of candesartan strongly suggest that the observed effects are specifically mediated by tonin-Ang II generation. Ang II was detectable under control conditions but promptly increased after the addition of tonin. Probably Ang II was formed by the action of tonin upon locally present substrate. Lindpaintner et al. [40] demonstrate that perfusion of the isolated, beating heart with renin causes dose-dependent appearance of Ang II in the coronary sinus effluent and that local synthesis is capable of responding to regulatory stimulation.
Altered Ca 2+ handling can influence cardiomyocyte physiology and changes in intracellular Ca 2+ are a major feature in heart failure and myocyte pathology [41] . To determine if the decrease in ST in isolated heart after tonin infusion is related to changes in cellular contractile function, we examined mechanical parameters in freshly isolated left ventricular myocytes from Wistar rats perfused with different tonin concentrations. Although the direct inotropic effect (cell shortening) of tonin was not observed, alterations in the velocities of contraction and relaxation were observed after tonin perfusion. The time to peak of cell shortening was significantly reduced and the time to half relaxation was significantly faster. This is an indication that Ca 2+ handling is accelerated by tonin. For instance, the faster the Ca 2+ release and re-uptake by the sarcoplasmic reticulum in rat left ventricular myocytes the faster the cell shortening and relaxation, respectively [42] . In conclusion we demonstrated that intravenous infusion of tonin in the rat affects BP and HR. Tonin is able to generate the pressor octapeptide Ang-II in the isolated rat heart and the cardiovascular (ACP, ST and HR) responses induced by tonin were completely blocked by candesartan, an indication that the action of Ang II on AT1 receptors is the major mechanism of the heart effects.
